Recently, BOC Sciences announced the release of a new generation non-viral in vivo transfection reagents platform for the delivery of a variety of samples to targeted organs (including kidney, liver, and pancreas). BOC Sciences’ in vivo transfection reagents have shown high transfection efficiency in mouse experiments, and this progress has opened the way to finding a reliable transfection method with real responses in vivo. —
As an effective form of molecular medicine, gene therapy is expected to have a significant impact on the treatment of human diseases (cancer, central nervous system diseases, genetic diseases, etc.). However, the current clinical use of gene therapy is plagued by inadequate gene delivery systems, which cannot ensure sufficient, accurate, and safe uptake of DNA by target cells in the body. Non-viral transfection methods may have the advantage of being safe to use and help increase the transfection rate of biomolecules in vivo.
BOC Sciences provides non-viral transfection reagents based on liposomes, polymers, and nanoparticles, designed to effectively deliver siRNA/microRNA/mRNA/plasmid DNA/small proteins in specific tissues. These transfection reagents use proprietary formulations to protect cargo biomolecules in the body and target tissues to deliver therapeutic compounds. And these transfection reagents have been tested for functionality in mice and rats, and various routes of administration (including intravenous, intraperitoneal and intratumoral injection) have been used in the test, showing an effective delivery effect without causing inflammation.
In addition, BOC Sciences also provides a variety of in vitro transfection reagents for primary cell types and difficult-to-transfect cell lines. For more information, please visit the website: https://transfection.bocsci.com.
About BOC Sciences
By providing researchers with a comprehensive range of biochemical products and services, BOC Sciences is closely related to drug development, chemistry, and life sciences. At the same time, it also provides a wide range of services at various stages of drug development to support the pharmaceutical industry, such as custom synthesis of chemicals, formulation services, drug delivery system development, etc.
Release ID: 88980502